SlideShare a Scribd company logo
ANEMIA 2
(SPECIFIC)
 Iron Deficiency Anemia(IDA)
 Anemia of Chronic Disease(ACD)
 Megaloblastic Anemia
 Hemolytic Anemia
 Other Types
Aplastic Anemia(AA)
Anemia of CRF
 Introduction
 Epidemiology
 Iron Metabolism
 Causes
 Clinical Features
 Diagnosis
 Differential Diagnoses
 Treatment
 The development & the rapidity of IDA is
dependent upon the body’s iron store.
 Iron store in turn depends on
◦ Age
◦ Sex
◦ Rate of growth
◦ Balance b/n loss & absorption
 Generally lower Iron values for women
because of menstrual loss, pregnancy,
lactation
 IDA is supposed to be one of the commonest
forms in our country
1 - 2% even in the Western countries
Iron deficiency without anemia 11% in women (men 4%)
 The WHO data on anemia 1997
2 billion people affected
Children & pregnant women most affected
 Prevalence
Young children 48%
Pregnant women51%
Non-pregnant women 35%
Adult men 18%
 On IDA
◦ Commonest among the nutritional anemias
◦ More prevalent in developing countries
 36% vs 8%
 Local data show similar pictures
◦ North Western Ethiopia
 General population 40.5%
 Children 47.2%
◦ Jimma
 57% has been reported in pregnant women
 Regulation of iron balance
◦ Interaction of various proteins
◦ Interplay b/n iron absorption & loss
 Transferrin (Tf) & its receptors (TfR)
 Ferritin
 Iron responsive element-binding protein(
IRE-BP), IRP/IRF
 HFE
 Divalent Metal Transporter( DMT1)
 Stimulator of iron transport(SFT)
 Ferroportin & Hephaestin
 Hepcidin
 Transports Fe3+ through plasma
 Synthesized in the liver
 Increased production in deficiency states
 Measured as Tf or TIBC
 1/3rd saturated normally
Fe/Tf = 33%
 States with decreased Tf saturation or
increased TIBC
IDA
ACD ( occasionally)
Ferroportin mutation
 States with increased Tf saturation or
decreased TIBC
Aplastic anemia
Sideroblastic anemia
Ineffective erythropoiesis
hemochromatosis
 Huge molecule for cellular storage of Fe
◦ 4500 atoms of iron
 Acute phase reactant
 Accessible for metabolic needs
 Excess is changed to Hemosiderin
◦ Hemosiderin is not easy accessible for metabolism
 Measured as apoferritin in the plasma
 Plasma level reflects body iron store
◦ 1ng of ferritin= 10mg of total iron store
 Normal body content = 3-4gm
 HGB = 2.5gm
 Other Fe containing proteins= 400mg
 Tf bound in the plasma= 3-7mg
 The rest as ferritin/hemosiderin= body Fe
store
◦ Adult men = 1gm
◦ Adult women = much less than men
 Daily iron loss = 1mg
 Diet contains heme & non-heme Fe
◦ 30% vs 10% absorbed
 Released in the acidic environment and is
sent with mucin to the doudenum for
absorption
 Enhancers vs Inhibitors
 Ferric vs ferrous
 Blood loss( major cause)
◦ Obvious or occult
◦ GI loss the main, including Hook worm
 Decreased absorption( uncommon)
◦ Part of generalized malabsorption like Celiac &
Tropical Sprue
 Others causes
◦ Pulmonary hemosiderosis
◦ Intravascular hemolysis
 Hemoglobinuria & hemosiderinuria
◦ Increased demand
 Rx with EPO, folate or Vitamin B12
 IDA has 3stage
 Stage 1
◦ Depleted iron store without anemia
◦ High risk of anemia with slightest bleeding
◦ Iron from daily RBC turn over
 Stage 2
◦ Normocytic
◦ Normal reticulocyte count
◦ Common in developed countries
 Stage 3
◦ Typical character
◦ In the face severe Fe deficiency
◦ Microcytic hypochromic
◦ Imbalance b/n heme & globulin synthesis
 High EPO
 LOW RETIC COUNT
 Features of anemia ( as discussed)
 Typical of IDA
◦ KOILONYCHIA( SPOON NAILS)
◦ BLUE SCLERA
◦ PICA & PAGOPHAGIA
◦ BEETURIA
◦ PATERSON-KELLY/PLUMMER-VINSON SYNDROME
 Dysphagia
 Oesophageal web
 Atrophic glossitis
 Low HGB, HCT, RBC counts
 Microcytic-hypochromic
◦ Low MCV, MCH &MCHC
◦ Increased central pallor
 High Platelet count( Reactive thrombocytosis)
 Normal WBC Count & Morphology
 Low serum iron & ferritin
 High Tf level
◦ Low saturation ( 2.5%)
◦ High TIBC
 Absent iron stores
 Brisk response to therapeutic trail
 The dx of IDA has 2 components
◦ Confirmation of iron deficiency
◦ Identify the cause
 CBC &ESR
 RBC INDICES
 PERIPHERAL SMEAR
 IRON STUDIES
◦ Serum iron
◦ Serum ferritin
◦ Serum Tf, TIBC
 BM STUDY
 THERAPEUTIC TRAIL & OTHERS
 History is vital
◦ Gynecologic
◦ History of surgery
◦ Dietary habit
 Stool exam
◦ Occult blood
◦ Ova of parasites
 Endoscopy
 colonoscopy
 When anemia is mild with normal indices
(Stage 2 IDA)
◦ ACD
◦ Anemia due to CRF
◦ Anemia due to endocrine disorders
 Classic(microcytic- hypochromic)
◦ Thalassemia
◦ Sideroblastic anemia
◦ ACD
◦ Lead poisoning
 Two aspects
◦ Treatment of the underlying cause
◦ Administration of iron
 General principles of iron treatment
Iron is absorbed in the duodenum & pro.jejunem
Shouldn’t be given with food
Best absorbed in a mildly acidic media
Give ascorbic acid
2hrs before or 4hrs after antacids
Cost and effectiveness
UGI discomfort is directly related to the amount of iron
Try the elixir
 Oral preparation
◦ Ferrous sulfate 65mg of elemental iron
◦ Ferrous fumarate 106mg of elemental iron
◦ Ferrous gluconate 28-36mg of elemental iron
◦ Ferrous sulfate elixir 44mg/5ml
 Side effect
◦ GI upset
 150-200mg of elemental iron
 Response to treatment
◦ Reticulocytosis in 7days
◦ Rise in HGB 2g% over 3weeks
◦ Reasons for failure
 Duration of treatment
◦ Continue after normalization of HGB to replenish
the iron stores
◦ 3-6months after normalization of HGB
 Parenteral iron
◦ IV or IM
◦ Preparations
 Iron dextran
 Ferric gluconate
 Iron sucrose
◦ Major side effects
 Local & systemic
INTRODUCTION
PATHOGENESIS
LABORATORY FINDINGS
TREATMENT
 Also called anemia of chronic inflammation
 ACD can be associated with conditions other
than inflammation, infection or malignancy:
Severe trauma
Heart disease
Diabetes
Acute or chronic immune reactivation
 Typically
NCNC
HYPOPROLIFERATIVE
 Primarily reflect a reduction in RBC
production but there may be a component
of RBC reduced survival
 Three factors for hypoproliferative state
◦ Trapping of iron in macrophages
◦ Reduced sensitivity of BM to EPO
 Normal marrow
 Increase apoptosis of RBC precursors
◦ Relative reduction in EPO
 Release of cytokines
◦ Interleukins
◦ TNF
◦ Interferon
◦ Hepcidin
 Acute variant
◦ “Anemia of critical illness”
◦ Acute event related
 Major surgery
 MI
 Sepsis
 Major trauma
 Anemia in ACD is of variable severity
◦ Many 10-11g% hgb
◦ Some(20%) will have HGB of 8g% or less
 Low absolute reticulocyte count
 High acute phase reactants & cytokines
 Low serum iron & Tf level(TIBC)
 1/4th of patients are iron deficient
 Serum ferritin normal or elevated
 Bone marrow
◦ Macrophages increased or normal iron content
◦ Erythroid precursers – decreased or absent
 ACD is usually NC & hypoproliferative
◦ CRF
◦ Severe endocrine disorders
 Some patients with severe anemia &
microcytic hypochromic picture
◦ IDA
◦ THALASSEMIA
◦ SIDEROBLASTIC ANEMIA
 Usually mild & may not interfere with quality
of life
 Correction of underlying problem
 Erythropoietin
◦ After measuring the level
◦ ?Survival
◦ Darbepoetin
 Supplemental iron
◦ To maintain 20% or above saturation of Tf
INTRODUCTION
CLINICAL PRESENTATION
LABORATORY FINDINGS & DX
TREATMENT
 Megaloblasts are nucleated RBC precursors
in the BM which maybe seen in rarely in
severe deficiency states
 Macrocytic anemia is more appropriate
 Anemia caused by vitamin B12(cobalamin)
deficiency and folate deficiency is similar
 Vitamin B12 deficiency
◦ Take longer time to develop
◦ Neurological manifestations may come early
 Folate deficiency
◦ Can develop in relatively short duration
 Pregnancy
 Acute & severe infection
 Severe hemolysis
 Classic presentation
◦ Anemia with MCV > 100fl(usually >115)
◦ Low –normal or low ARC
◦ Macro-ovalocytes
 ?megaloblasts
◦ Hypersegemented neutrophils
 Masked by iron deficiency/ thalassemia
 Neurologic manifestation
◦ Cyanobalamin
◦ Without anemia
 Only hypersegemented neutrophils
 Evaluation has two stages
◦ Deficiency state
◦ Cause
 History very important
 CBC
 Peripheral smear
 Serum Cbl level
 RBC folate level
 Specific metabolites
◦ Elevated methylmalonic acid(MMA)
 ONLY IN CBL def
◦ Elevated homocysteine
 Both folate & Cbl deficiency
 BM
 Other tests
◦ Schilling test( 3 stages)
◦ Antibodies
 Intrinsic factor
 Parietal cell
 Empiric treatment in the case of folate
deficiency
 Folate deficiency
◦ 1-5mg/day oral
◦ For 1-4months
◦ Complete hematologic recovery
 Reduction in LDH in 2days
 Reticulocytosis in 3-4days(peak in 1wk)
 Rise in HBG & reduction in MCV in 8wks
 Delay in cases of iron deficiency
 Cobalamine deficiency
◦ IM CBL
 1000microgram(1mg) daily for 1wk
 1mg/wk for 1month
 1mg/month then after
 Cause not known or PA- give for life monthly
INTRODUCTION
RBC KINETICS
CLASSIFICATIONS
DIAGNOSTIC APPROACH
 HA
◦ Vast group
◦ Important cause of anemia
◦ Shorted RBC survival
◦ Splenomegaly(hypersplenism)
 Hemolysis
◦ Shorted RBC survival less than 100days
◦ Normal RBC survival- 120days
◦ Not necessarily HA
 Random hemolysis
◦ Another way of RBC destruction besides the
death of aging (senescent) RBC
◦ Age independent
◦ Very low rate
 Less than 0.05-0.5%
 Increased in the case of splenomegaly & HA
◦ Well compensated normally by
 Increased EPO production
 Reticulocytosis
 RBC lifespan & turnover
◦ Estimated from
 Reticulocyte percent
 HCT
 Reticulocyte life span
◦ Formula
 RBC survival (days) = 100/[retic%/RLS(days)]
 RBC turnover(%/d) = 100/RBC survival (days)
 Absolute reticulocyte count
◦ Reticulocyte percent may not give all the
information about the BM response
◦ Normal value
 25,000-75,000/microL
◦ Can be counted
◦ Corrected
 Corrected ARC= ARC/retic maturation time
 More informative
 Reticulocyte production index(RPI)
◦ Two corrections
 Survival shift
 Degree of anemia
◦ Formula
 RPI= retic% x (HCT/45) x ½
 Normal 1
 Different ways of classification of causes of
HA
◦ Intracorpuscular/ Extracorpuscular
◦ Inherited/ Acquired
◦ Intravascular/ extravascular
◦ Immune-mediated/ non-immune mediated
 Immune mediated
 Warm/ cold Antibody
 Starts with an accurate hx & P/E
 Classic case
◦ New onset of pallor or anemia
◦ Jaundice ( high indirect bilirubin)
◦ Gallstones
◦ Splenomegaly
◦ Presence of circulating spherocytic RC
◦ Increased LDH
◦ Decreased serum haptoglobin
◦ + Coomb’s test
◦ High retic % or ARC
 Peripheral smear
◦ Spherocytes
◦ Fragmented RBC
◦ Acanthocytes (spur cell)
◦ Teardrop cell
◦ Blister or “ bite” cells
◦ RBC inclusions
◦ Parasites
 Other forms of anemia
◦ Aplastic amemia
 Idiopathic
 Acquired
◦ HA
 AIHA
◦ ANEMIA OF CRF
Specific Anemias.ppt
Specific Anemias.ppt

More Related Content

Similar to Specific Anemias.ppt

IRON DEFICIENCY ANEMIA
IRON DEFICIENCY ANEMIAIRON DEFICIENCY ANEMIA
IRON DEFICIENCY ANEMIA
Keshav Chandra
 
Approach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemiaApproach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemia
Sachin Adukia
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
Akebom Gebremichael
 
IRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptxIRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptx
Santurims
 
Anemia in children.pptx
Anemia in children.pptxAnemia in children.pptx
Anemia in children.pptx
PAEDIATRICIANSLIMS1
 
Fluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relationFluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relation
drdduttaM
 
Microcytic hypochromic anemia
Microcytic hypochromic anemia Microcytic hypochromic anemia
Microcytic hypochromic anemia
Ahmed Abdelhakeem
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
Mohammad Ihmeidan
 
Anemia simi joju k.
Anemia simi joju k.Anemia simi joju k.
Anemia simi joju k.
simisheeja
 
Anaemia & other haematological disorders
Anaemia & other haematological disordersAnaemia & other haematological disorders
Anaemia & other haematological disorders
Sneha Jadhav
 
Diseases of the Blood in children.ppt
Diseases of the Blood in children.pptDiseases of the Blood in children.ppt
Diseases of the Blood in children.ppt
RaheelAhmed210939
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
Bharati vidyapeeth university
 
anaemiainpregnancy-190208054001.pdf
anaemiainpregnancy-190208054001.pdfanaemiainpregnancy-190208054001.pdf
anaemiainpregnancy-190208054001.pdf
AshishSharma907946
 
Anemia.pdf
Anemia.pdfAnemia.pdf
Anemia.pdf
ShabnamSajida
 
Approach to microcytic anemia
Approach to microcytic anemiaApproach to microcytic anemia
Approach to microcytic anemia
Bikal Lamichhane
 
Anaemia and pathology
Anaemia and pathologyAnaemia and pathology
Anaemia and pathology
George Wild
 
Anemia in elderly
Anemia in elderlyAnemia in elderly
Anemia in elderly
Chetan Ganteppanavar
 
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev KumarErythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
Dr. Sookun Rajeev Kumar
 
Iron deficiency anemia management, risk factors, physiology of iron absorption
Iron deficiency anemia management, risk factors, physiology of iron absorptionIron deficiency anemia management, risk factors, physiology of iron absorption
Iron deficiency anemia management, risk factors, physiology of iron absorption
nagapraneeth21d
 
Hematology
HematologyHematology
Hematology
DJ CrissCross
 

Similar to Specific Anemias.ppt (20)

IRON DEFICIENCY ANEMIA
IRON DEFICIENCY ANEMIAIRON DEFICIENCY ANEMIA
IRON DEFICIENCY ANEMIA
 
Approach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemiaApproach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemia
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
IRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptxIRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptx
 
Anemia in children.pptx
Anemia in children.pptxAnemia in children.pptx
Anemia in children.pptx
 
Fluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relationFluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relation
 
Microcytic hypochromic anemia
Microcytic hypochromic anemia Microcytic hypochromic anemia
Microcytic hypochromic anemia
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
 
Anemia simi joju k.
Anemia simi joju k.Anemia simi joju k.
Anemia simi joju k.
 
Anaemia & other haematological disorders
Anaemia & other haematological disordersAnaemia & other haematological disorders
Anaemia & other haematological disorders
 
Diseases of the Blood in children.ppt
Diseases of the Blood in children.pptDiseases of the Blood in children.ppt
Diseases of the Blood in children.ppt
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
 
anaemiainpregnancy-190208054001.pdf
anaemiainpregnancy-190208054001.pdfanaemiainpregnancy-190208054001.pdf
anaemiainpregnancy-190208054001.pdf
 
Anemia.pdf
Anemia.pdfAnemia.pdf
Anemia.pdf
 
Approach to microcytic anemia
Approach to microcytic anemiaApproach to microcytic anemia
Approach to microcytic anemia
 
Anaemia and pathology
Anaemia and pathologyAnaemia and pathology
Anaemia and pathology
 
Anemia in elderly
Anemia in elderlyAnemia in elderly
Anemia in elderly
 
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev KumarErythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev Kumar
 
Iron deficiency anemia management, risk factors, physiology of iron absorption
Iron deficiency anemia management, risk factors, physiology of iron absorptionIron deficiency anemia management, risk factors, physiology of iron absorption
Iron deficiency anemia management, risk factors, physiology of iron absorption
 
Hematology
HematologyHematology
Hematology
 

More from mulugeta asmamaw

Bronchial Asthma.pptx
Bronchial Asthma.pptxBronchial Asthma.pptx
Bronchial Asthma.pptx
mulugeta asmamaw
 
acuteleukemias-_1.pptx
acuteleukemias-_1.pptxacuteleukemias-_1.pptx
acuteleukemias-_1.pptx
mulugeta asmamaw
 
Malaria ppt c-1.pptx
Malaria ppt c-1.pptxMalaria ppt c-1.pptx
Malaria ppt c-1.pptx
mulugeta asmamaw
 
Overview of ILDs.pptx
Overview of ILDs.pptxOverview of ILDs.pptx
Overview of ILDs.pptx
mulugeta asmamaw
 
Lung Cancer.pptx
Lung Cancer.pptxLung Cancer.pptx
Lung Cancer.pptx
mulugeta asmamaw
 
suprative.ppt
suprative.pptsuprative.ppt
suprative.ppt
mulugeta asmamaw
 

More from mulugeta asmamaw (6)

Bronchial Asthma.pptx
Bronchial Asthma.pptxBronchial Asthma.pptx
Bronchial Asthma.pptx
 
acuteleukemias-_1.pptx
acuteleukemias-_1.pptxacuteleukemias-_1.pptx
acuteleukemias-_1.pptx
 
Malaria ppt c-1.pptx
Malaria ppt c-1.pptxMalaria ppt c-1.pptx
Malaria ppt c-1.pptx
 
Overview of ILDs.pptx
Overview of ILDs.pptxOverview of ILDs.pptx
Overview of ILDs.pptx
 
Lung Cancer.pptx
Lung Cancer.pptxLung Cancer.pptx
Lung Cancer.pptx
 
suprative.ppt
suprative.pptsuprative.ppt
suprative.ppt
 

Recently uploaded

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 

Recently uploaded (20)

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 

Specific Anemias.ppt

  • 2.  Iron Deficiency Anemia(IDA)  Anemia of Chronic Disease(ACD)  Megaloblastic Anemia  Hemolytic Anemia  Other Types Aplastic Anemia(AA) Anemia of CRF
  • 3.  Introduction  Epidemiology  Iron Metabolism  Causes  Clinical Features  Diagnosis  Differential Diagnoses  Treatment
  • 4.  The development & the rapidity of IDA is dependent upon the body’s iron store.  Iron store in turn depends on ◦ Age ◦ Sex ◦ Rate of growth ◦ Balance b/n loss & absorption  Generally lower Iron values for women because of menstrual loss, pregnancy, lactation
  • 5.  IDA is supposed to be one of the commonest forms in our country 1 - 2% even in the Western countries Iron deficiency without anemia 11% in women (men 4%)  The WHO data on anemia 1997 2 billion people affected Children & pregnant women most affected  Prevalence Young children 48% Pregnant women51% Non-pregnant women 35% Adult men 18%
  • 6.  On IDA ◦ Commonest among the nutritional anemias ◦ More prevalent in developing countries  36% vs 8%  Local data show similar pictures ◦ North Western Ethiopia  General population 40.5%  Children 47.2% ◦ Jimma  57% has been reported in pregnant women
  • 7.  Regulation of iron balance ◦ Interaction of various proteins ◦ Interplay b/n iron absorption & loss
  • 8.  Transferrin (Tf) & its receptors (TfR)  Ferritin  Iron responsive element-binding protein( IRE-BP), IRP/IRF  HFE  Divalent Metal Transporter( DMT1)  Stimulator of iron transport(SFT)  Ferroportin & Hephaestin  Hepcidin
  • 9.  Transports Fe3+ through plasma  Synthesized in the liver  Increased production in deficiency states  Measured as Tf or TIBC  1/3rd saturated normally Fe/Tf = 33%
  • 10.  States with decreased Tf saturation or increased TIBC IDA ACD ( occasionally) Ferroportin mutation  States with increased Tf saturation or decreased TIBC Aplastic anemia Sideroblastic anemia Ineffective erythropoiesis hemochromatosis
  • 11.  Huge molecule for cellular storage of Fe ◦ 4500 atoms of iron  Acute phase reactant  Accessible for metabolic needs  Excess is changed to Hemosiderin ◦ Hemosiderin is not easy accessible for metabolism  Measured as apoferritin in the plasma  Plasma level reflects body iron store ◦ 1ng of ferritin= 10mg of total iron store
  • 12.  Normal body content = 3-4gm  HGB = 2.5gm  Other Fe containing proteins= 400mg  Tf bound in the plasma= 3-7mg  The rest as ferritin/hemosiderin= body Fe store ◦ Adult men = 1gm ◦ Adult women = much less than men  Daily iron loss = 1mg
  • 13.  Diet contains heme & non-heme Fe ◦ 30% vs 10% absorbed  Released in the acidic environment and is sent with mucin to the doudenum for absorption  Enhancers vs Inhibitors  Ferric vs ferrous
  • 14.
  • 15.
  • 16.
  • 17.  Blood loss( major cause) ◦ Obvious or occult ◦ GI loss the main, including Hook worm  Decreased absorption( uncommon) ◦ Part of generalized malabsorption like Celiac & Tropical Sprue
  • 18.  Others causes ◦ Pulmonary hemosiderosis ◦ Intravascular hemolysis  Hemoglobinuria & hemosiderinuria ◦ Increased demand  Rx with EPO, folate or Vitamin B12
  • 19.  IDA has 3stage  Stage 1 ◦ Depleted iron store without anemia ◦ High risk of anemia with slightest bleeding ◦ Iron from daily RBC turn over
  • 20.  Stage 2 ◦ Normocytic ◦ Normal reticulocyte count ◦ Common in developed countries
  • 21.  Stage 3 ◦ Typical character ◦ In the face severe Fe deficiency ◦ Microcytic hypochromic ◦ Imbalance b/n heme & globulin synthesis  High EPO  LOW RETIC COUNT
  • 22.
  • 23.  Features of anemia ( as discussed)  Typical of IDA ◦ KOILONYCHIA( SPOON NAILS) ◦ BLUE SCLERA ◦ PICA & PAGOPHAGIA ◦ BEETURIA ◦ PATERSON-KELLY/PLUMMER-VINSON SYNDROME  Dysphagia  Oesophageal web  Atrophic glossitis
  • 24.  Low HGB, HCT, RBC counts  Microcytic-hypochromic ◦ Low MCV, MCH &MCHC ◦ Increased central pallor  High Platelet count( Reactive thrombocytosis)  Normal WBC Count & Morphology
  • 25.  Low serum iron & ferritin  High Tf level ◦ Low saturation ( 2.5%) ◦ High TIBC  Absent iron stores  Brisk response to therapeutic trail
  • 26.
  • 27.  The dx of IDA has 2 components ◦ Confirmation of iron deficiency ◦ Identify the cause
  • 28.  CBC &ESR  RBC INDICES  PERIPHERAL SMEAR  IRON STUDIES ◦ Serum iron ◦ Serum ferritin ◦ Serum Tf, TIBC  BM STUDY  THERAPEUTIC TRAIL & OTHERS
  • 29.  History is vital ◦ Gynecologic ◦ History of surgery ◦ Dietary habit  Stool exam ◦ Occult blood ◦ Ova of parasites  Endoscopy  colonoscopy
  • 30.  When anemia is mild with normal indices (Stage 2 IDA) ◦ ACD ◦ Anemia due to CRF ◦ Anemia due to endocrine disorders  Classic(microcytic- hypochromic) ◦ Thalassemia ◦ Sideroblastic anemia ◦ ACD ◦ Lead poisoning
  • 31.  Two aspects ◦ Treatment of the underlying cause ◦ Administration of iron
  • 32.  General principles of iron treatment Iron is absorbed in the duodenum & pro.jejunem Shouldn’t be given with food Best absorbed in a mildly acidic media Give ascorbic acid 2hrs before or 4hrs after antacids Cost and effectiveness UGI discomfort is directly related to the amount of iron Try the elixir
  • 33.  Oral preparation ◦ Ferrous sulfate 65mg of elemental iron ◦ Ferrous fumarate 106mg of elemental iron ◦ Ferrous gluconate 28-36mg of elemental iron ◦ Ferrous sulfate elixir 44mg/5ml  Side effect ◦ GI upset
  • 34.  150-200mg of elemental iron  Response to treatment ◦ Reticulocytosis in 7days ◦ Rise in HGB 2g% over 3weeks ◦ Reasons for failure  Duration of treatment ◦ Continue after normalization of HGB to replenish the iron stores ◦ 3-6months after normalization of HGB
  • 35.  Parenteral iron ◦ IV or IM ◦ Preparations  Iron dextran  Ferric gluconate  Iron sucrose ◦ Major side effects  Local & systemic
  • 37.  Also called anemia of chronic inflammation  ACD can be associated with conditions other than inflammation, infection or malignancy: Severe trauma Heart disease Diabetes Acute or chronic immune reactivation
  • 39.  Primarily reflect a reduction in RBC production but there may be a component of RBC reduced survival
  • 40.  Three factors for hypoproliferative state ◦ Trapping of iron in macrophages ◦ Reduced sensitivity of BM to EPO  Normal marrow  Increase apoptosis of RBC precursors ◦ Relative reduction in EPO
  • 41.  Release of cytokines ◦ Interleukins ◦ TNF ◦ Interferon ◦ Hepcidin
  • 42.  Acute variant ◦ “Anemia of critical illness” ◦ Acute event related  Major surgery  MI  Sepsis  Major trauma
  • 43.  Anemia in ACD is of variable severity ◦ Many 10-11g% hgb ◦ Some(20%) will have HGB of 8g% or less  Low absolute reticulocyte count  High acute phase reactants & cytokines  Low serum iron & Tf level(TIBC)
  • 44.  1/4th of patients are iron deficient  Serum ferritin normal or elevated  Bone marrow ◦ Macrophages increased or normal iron content ◦ Erythroid precursers – decreased or absent
  • 45.  ACD is usually NC & hypoproliferative ◦ CRF ◦ Severe endocrine disorders
  • 46.  Some patients with severe anemia & microcytic hypochromic picture ◦ IDA ◦ THALASSEMIA ◦ SIDEROBLASTIC ANEMIA
  • 47.  Usually mild & may not interfere with quality of life  Correction of underlying problem  Erythropoietin ◦ After measuring the level ◦ ?Survival ◦ Darbepoetin  Supplemental iron ◦ To maintain 20% or above saturation of Tf
  • 49.  Megaloblasts are nucleated RBC precursors in the BM which maybe seen in rarely in severe deficiency states  Macrocytic anemia is more appropriate  Anemia caused by vitamin B12(cobalamin) deficiency and folate deficiency is similar
  • 50.  Vitamin B12 deficiency ◦ Take longer time to develop ◦ Neurological manifestations may come early  Folate deficiency ◦ Can develop in relatively short duration  Pregnancy  Acute & severe infection  Severe hemolysis
  • 51.
  • 52.
  • 53.
  • 54.  Classic presentation ◦ Anemia with MCV > 100fl(usually >115) ◦ Low –normal or low ARC ◦ Macro-ovalocytes  ?megaloblasts ◦ Hypersegemented neutrophils
  • 55.  Masked by iron deficiency/ thalassemia  Neurologic manifestation ◦ Cyanobalamin ◦ Without anemia  Only hypersegemented neutrophils
  • 56.
  • 57.  Evaluation has two stages ◦ Deficiency state ◦ Cause  History very important  CBC  Peripheral smear  Serum Cbl level  RBC folate level
  • 58.  Specific metabolites ◦ Elevated methylmalonic acid(MMA)  ONLY IN CBL def ◦ Elevated homocysteine  Both folate & Cbl deficiency  BM  Other tests ◦ Schilling test( 3 stages) ◦ Antibodies  Intrinsic factor  Parietal cell  Empiric treatment in the case of folate deficiency
  • 59.
  • 60.  Folate deficiency ◦ 1-5mg/day oral ◦ For 1-4months ◦ Complete hematologic recovery  Reduction in LDH in 2days  Reticulocytosis in 3-4days(peak in 1wk)  Rise in HBG & reduction in MCV in 8wks  Delay in cases of iron deficiency
  • 61.  Cobalamine deficiency ◦ IM CBL  1000microgram(1mg) daily for 1wk  1mg/wk for 1month  1mg/month then after  Cause not known or PA- give for life monthly
  • 63.  HA ◦ Vast group ◦ Important cause of anemia ◦ Shorted RBC survival ◦ Splenomegaly(hypersplenism)  Hemolysis ◦ Shorted RBC survival less than 100days ◦ Normal RBC survival- 120days ◦ Not necessarily HA
  • 64.  Random hemolysis ◦ Another way of RBC destruction besides the death of aging (senescent) RBC ◦ Age independent ◦ Very low rate  Less than 0.05-0.5%  Increased in the case of splenomegaly & HA ◦ Well compensated normally by  Increased EPO production  Reticulocytosis
  • 65.  RBC lifespan & turnover ◦ Estimated from  Reticulocyte percent  HCT  Reticulocyte life span ◦ Formula  RBC survival (days) = 100/[retic%/RLS(days)]  RBC turnover(%/d) = 100/RBC survival (days)
  • 66.
  • 67.  Absolute reticulocyte count ◦ Reticulocyte percent may not give all the information about the BM response ◦ Normal value  25,000-75,000/microL ◦ Can be counted ◦ Corrected  Corrected ARC= ARC/retic maturation time  More informative  Reticulocyte production index(RPI) ◦ Two corrections  Survival shift  Degree of anemia ◦ Formula  RPI= retic% x (HCT/45) x ½  Normal 1
  • 68.  Different ways of classification of causes of HA ◦ Intracorpuscular/ Extracorpuscular ◦ Inherited/ Acquired ◦ Intravascular/ extravascular ◦ Immune-mediated/ non-immune mediated  Immune mediated  Warm/ cold Antibody
  • 69.
  • 70.  Starts with an accurate hx & P/E  Classic case ◦ New onset of pallor or anemia ◦ Jaundice ( high indirect bilirubin) ◦ Gallstones ◦ Splenomegaly ◦ Presence of circulating spherocytic RC ◦ Increased LDH ◦ Decreased serum haptoglobin ◦ + Coomb’s test ◦ High retic % or ARC
  • 71.  Peripheral smear ◦ Spherocytes ◦ Fragmented RBC ◦ Acanthocytes (spur cell) ◦ Teardrop cell ◦ Blister or “ bite” cells ◦ RBC inclusions ◦ Parasites
  • 72.  Other forms of anemia ◦ Aplastic amemia  Idiopathic  Acquired ◦ HA  AIHA ◦ ANEMIA OF CRF